ALDX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) and its officers. The lawsuit alleges that the company made false and misleading statements regarding the inconsistent results of its reproxalap clinical trials. Investors who purchased Aldeyra securities between November 3, 2023, and March 16, 2026, and suffered losses, have until May 29, 2026, to seek lead plaintiff status.